Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential
Open Access
- 21 July 2003
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 10 (8) , 583-588
- https://doi.org/10.1038/sj.cgt.7700606
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified AdenovirusesMolecular Therapy, 2002
- Adenoviruses in OncologyBioDrugs, 2002
- Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K regionGene Therapy, 2001
- Update on adenovirus and its vectorsJournal of General Virology, 2000
- Ectodomain of Coxsackievirus and Adenovirus Receptor Genetically Fused to Epidermal Growth Factor Mediates Adenovirus Targeting to Epidermal Growth Factor Receptor-Positive CellsJournal of Virology, 2000
- Reversible G1 Arrest Induced by Inhibition of the Epidermal Growth Factor Receptor Tyrosine Kinase Requires Up-regulation of p27KIP1 Independent of MAPK ActivityJournal of Biological Chemistry, 2000
- A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivoOncogene, 2000
- Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancerGene Therapy, 1999
- Herpes Simplex Virus Thymidine Kinase-Green Fluorescent Protein Fusion Gene: New Tool for Gene Transfer Studies and Gene TherapyBioTechniques, 1998
- Cancer Cell CyclesScience, 1996